Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits hepatocellular carcinoma in vitro and in vivo via stabilizing IkBα. 2012

George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. gchen@cuhk.edu.hk

Ent-11-hydroxy-15-oxo-kaur-16-en-19-oic-acid (5F) isolated from Pteris Semipinnata L is known to inhibit certain tumor cells in vitro. The information on the in vivo effect of 5F is limited and its effect on hepatocellular carcinoma (HCC) is unknown. In this study, the anti-tumor effect of 5F was investigated in a diethylnitrosamine (DEN)-induced mouse HCC model. In addition to therapeutic effect, the potential side effect was monitored. A panel of cultured HCC cells was used to confirm the in vivo data and explore the responsible molecular pathway. The result showed that 5F significantly inhibited the DEN-induced HCC tumors by reducing the number of tumor foci and the volume of tumors. Furthermore, 5F induced the death of cultured HCC cells in dose- and time-dependent manners. The cell death was confirmed to be apoptotic by in vivo and in vitro TUNEL assays. 5F inhibited NF-kB by stabilizing its inhibitor IkBα, reducing the nuclear p65 and inhibiting NF-kB activity. Subsequently it affected the NF-kB downstream molecules with a decrease in anti-apoptotic Bcl-2 and increase in pro-apoptotic Bax and Bak. During the whole period of the experiment, mice receiving 5F appeared to be healthy, though they suffered from a mild degree of hair loss. 5F did not damage liver and renal functions. In conclusion, 5F is effective against HCC with minimal side effects. It induces apoptosis in HCC cells via inhibiting NF-kB, leading to the decrease of Bcl-2 but the increase of Bax and Bak.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004052 Diethylnitrosamine A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. Nitrosodiethylamine,N-Nitrosodiethylamine,N Nitrosodiethylamine
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics

Related Publications

George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
December 2012, Current drug targets,
George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
June 2013, Oncology reports,
George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
August 2011, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
April 2016, Molecular medicine reports,
George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
January 2017, Skin pharmacology and physiology,
George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
December 2017, Oncology letters,
George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
March 2021, The Analyst,
George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
June 2012, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu,
George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
November 2010, Head & neck,
George G Chen, and Jackie Leung, and Nian Ci Liang, and Li Li, and Kefeng Wu, and Ursula P F Chan, and Billy C S Leung, and Mingyue Li, and Jing Du, and Yi Feng Deng, and Xianling Gong, and Yingnian Lv, and Ernest C W Chak, and Paul B S Lai
January 2020, Foods (Basel, Switzerland),
Copied contents to your clipboard!